Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

No abstract available
Original languageEnglish
Pages (from-to)1458-1460
Number of pages3
JournalTHE BREAST JOURNAL
Volume26
DOIs
Publication statusPublished - 2020

Keywords

  • Breast cancer
  • econd-line treatment
  • palbociclyb

Fingerprint

Dive into the research topics of 'Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?'. Together they form a unique fingerprint.

Cite this